41 studies found for:    " February 27, 2008":" March 28, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Raltegravir Intensification in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
22 Completed
Has Results
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
Conditions: HIV Infections;   Hyperlipidemia
Interventions: Drug: Pravastatin;   Drug: Darunavir;   Drug: Ritonavir;   Other: Washout
23 Completed Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Abacavir
24 Completed Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
25 Unknown  Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men
Condition: HIV Infections
Interventions: Behavioral: Standard Text-Based Prevention Web Page;   Behavioral: The Morning After;   Behavioral: Talking About HIV;   Behavioral: Both Videos
26 Completed Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
Conditions: HIV Infections;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling
27 Completed Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate;   Drug: Tenofovir DF placebo
28 Completed Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
Conditions: HIV Infections;   Tuberculosis
Interventions: Device: QuantiFERON TB Gold In-Tube;   Device: T-SPOT.TB®
29 Completed
Has Results
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
Condition: HIV Infections
Intervention:
30 Completed Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: HIV immune globulin solution
31 Completed Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial
Condition: HIV Infections
Interventions: Drug: EFV+TDF;   Drug: EFV+3TC+TDF
32 Completed
Has Results
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Conditions: HIV Infections;   Type 2 Diabetes;   Obesity;   HIV;   AIDS;   Cardiovascular Disease;   Lipodystrophy
Interventions: Drug: Pioglitazone;   Behavioral: Exercise training
33 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
34 Completed Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir
35 Completed Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
Condition: Oral Candidiasis
Intervention: Drug: PAC113
36 Completed
Has Results
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Condition: HIV Infection
Intervention: Drug: Tenofovir + emtricitabine  + raltegravir.
37 Completed Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
38 Completed TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.
Condition: HIV
Intervention: Drug: TMC114; darunavir; Prezista
39 Completed
Has Results
Drug Interaction Study
Condition: Antivirals/HIV
Interventions: Drug: Rifabutin;   Drug: Rifabutin + Atazanavir + Ritonavir
40 Withdrawn Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
Condition: Pneumocystis Carinii Pneumonia
Interventions: Drug: Antibiotics only;   Drug: Antibiotics + Corticosteroids;   Drug: Corticosteroids + antibiotics

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years